Dan M Jones

Patterns of molecular response to and relapse after combination of sorafenib, idarubicin, and cytarabine in patients with FLT3 mutant acute myeloid leukemia.

H. Kantarjian, J. Cortes, F. Ravandi, 2011, Clinical lymphoma, myeloma & leukemia.

inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases.

H. Kantarjian, J. Cortes, L. Medeiros, 2005, American journal of clinical pathology.

inv(16)(p13q22) in Chronic Myelogenous Leukemia in Blast Phase

H. Kantarjian, J. Cortes, L. Medeiros, 2005 .

Reticulum Cell Sarcoma of Lymph Node with Mixed Dendritic and Fibroblastic Features

M. Amin, L. Medeiros, N. Ordóñez, 2001, Modern Pathology.

Predictors of primary imatinib resistance in chronic myelogenous leukemia are distinct from those in secondary imatinib resistance.

H. Kantarjian, J. Cortes, E. Jabbour, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

T-cell prolymphocytic leukemia: a single-institution experience.

H. Kantarjian, G. Garcia-Manero, J. Cortes, 2005, Clinical lymphoma & myeloma.

Phase II trial of denileukin diftitox for relapsed/refractory T‐cell non‐Hodgkin lymphoma

Dan Jones, Maria A. Rodriguez, P. Mclaughlin, 2007, British journal of haematology.

Pentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes.

Terry L. Smith, Maria A. Rodriguez, P. Mclaughlin, 2003, Oncology reports.

Nonlymphoid Lesions of the Lymph Nodes

L. Medeiros, Dan M Jones, Dan M. Jones, 2011 .